Status:
UNKNOWN
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Breast Neoplasms
Endometrial Neoplasms
Eligibility:
FEMALE
Phase:
PHASE2
Brief Summary
Thermal therapy (hyperthermia of heat) can increase the effect of chemotherapy treatments. By itself, thermal therapy can also kill cancer cells. By using thermal therapy to treat the whole body, the ...
Detailed Description
Once a patient has been accepted for this study, the patient will need to have a Central Venous line (CV line or port) if they do not already have one. (this may be placed by the patient's own doctor,...
Eligibility Criteria
Inclusion
- Resistant breast, endometrial, cervix, or ovarian cancer
- No active metastasis to the brain
- No more than 8 previous regimes of Doxil
- Successful completion of preliminary function tests
- Good ECOG score
Exclusion
- Active metastasis to the brain
- 8 or more previous cycles of Doxil
- Poor completion of preliminary function tests
- Poor ECOG score
Key Trial Info
Start Date :
June 1 1996
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00178802
Start Date
June 1 1996
End Date
December 1 2010
Last Update
April 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Hermann Hospital
Houston, Texas, United States, 77030